|
C5ORF28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.02300406929135E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.677800E-02 |
| Stage1-vs-Stage3 |
7.043600E-01 |
| Stage1-vs-Stage4 |
3.81460000000722E-05 |
| Stage2-vs-Stage3 |
3.590400E-02 |
| Stage2-vs-Stage4 |
1.626460E-04 |
| Stage3-vs-Stage4 |
4.378700E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.50353079880961E-12 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
9.086200E-01 |
| Caucasian-vs-Asian |
8.137000E-01 |
| AfricanAmerican-vs-Asian |
9.665200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.569360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
3.790700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.744000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.243560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.007800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.860000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.368400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.370800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.421600E-02 |
| Classical-VS-Follicular |
9.18230000035436E-07 |
| Classical-VS-Other |
7.965600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
5.90240000208908E-08 |
| Tall-VS-Other |
2.259400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.015000E-03 |
| Follicular-VS-Normal |
1.28389521236727E-11 |
| Other-VS-Normal |
4.63900029501474E-11 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
2.403300E-03 |
|
|
